AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding AIM ImmunoTech Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 38 | 43 | +5 |
| Shares | 7.30M | 7.47M | +164.2K (+2.2%) |
| Value | $14.7M | $6.86M | −$7.88M (−53.5%) |
New holders (10)
Institutions that held AIM ImmunoTech Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 705,100 | $649.0K | 0.00% |
| Citadel Advisors LLC | 41,052 | $37.0K | 0.00% |
| Virtu Financial LLC | 37,657 | $35.0K | 0.00% |
| Jane Street Group, LLC | 15,499 | $14.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,872 | $4.00K | 0.00% |
| Stephens Consulting, LLC | 3,000 | $2.76K | 0.00% |
| Hoey Investments, Inc | 1,000 | $1.00K | 0.00% |
| TD Waterhouse Canada Inc. | 170 | $220 | 0.00% |
| FMR LLC | 100 | $0 | 0.00% |
| Royal Bank of Canada | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held AIM ImmunoTech Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 46,679 | $94.0K |
| Arkadios Wealth Advisors | 21,597 | $43.0K |
| Alpine Global Management, LLC | 18,774 | $38.0K |
| Qube Research & Technologies Ltd | 15,826 | $32.0K |
| Jacobi Capital Management LLC | 2 | $0 |